Literature DB >> 15295125

Changing epidemiology of genital herpes simplex virus infection in Melbourne, Australia, between 1980 and 2003.

T Tran1, J D Druce, M C Catton, H Kelly, C J Birch.   

Abstract

OBJECTIVE: To investigate changes in the proportions of patients infected with genital herpes simplex virus (HSV) types 1 and 2 from 1980 to 2003 in Melbourne, Australia.
METHODS: A total of 25 372 patients were studied retrospectively. The proportions of HSV-1 and HSV-2 detected in these individuals were analysed by age, sex, and genital site.
RESULTS: In 1980 only 15.8% of HSV positive genital specimens were HSV-1 compared to 34.9% in 2003. In 2003 HSV-1 was detected in 77% of patients aged less than 20 years. Females were more likely to be infected with HSV-1, although the rate of increased detection was more pronounced in males. Except for females over the age of 40, the trend for the increase in HSV-1 was detected in all age groups. No specific genital site in either sex was associated with the increase.
CONCLUSIONS: The proportion of genital HSV-1 has increased in Australian patients, although HSV-2 is still the most common cause of genital infection. Confirmation of HSV type is necessary for optimal patient management.

Entities:  

Mesh:

Year:  2004        PMID: 15295125      PMCID: PMC1744857          DOI: 10.1136/sti.2004.009753

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  19 in total

1.  Commentary: developing preventive strategies in Europe.

Authors:  F M Cowan
Journal:  Int J Epidemiol       Date:  2001-06       Impact factor: 7.196

2.  A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.

Authors:  A G Langenberg; L Corey; R L Ashley; W P Leong; S E Straus
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

3.  Utility of a multiplex PCR assay for detecting herpesvirus DNA in clinical samples.

Authors:  Julian Druce; Mike Catton; Doris Chibo; Kirsty Minerds; David Tyssen; Renata Kostecki; Bill Maskill; Wendy Leong-Shaw; Marie Gerrard; Chris Birch
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

4.  Ethnic variation in type of genital herpes simplex virus infection in a South London genitourinary medicine clinic.

Authors:  M Strutt; J Bailey; M Tenant-Flowers; D Graham; M Zuckerman
Journal:  J Med Virol       Date:  2003-01       Impact factor: 2.327

5.  Six-year study of the incidence of herpes in genital and nongenital cultures in a central Kentucky medical center patient population.

Authors:  J A Ribes; A D Steele; J P Seabolt; D J Baker
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

6.  Changing trends in genital herpes simplex virus infection in Bergen, Norway.

Authors:  A Nilsen; H Myrmel
Journal:  Acta Obstet Gynecol Scand       Date:  2000-08       Impact factor: 3.636

7.  Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994.

Authors:  Fujie Xu; Julia A Schillinger; Maya R Sternberg; Robert E Johnson; Francis K Lee; Andre J Nahmias; Lauri E Markowitz
Journal:  J Infect Dis       Date:  2002-03-22       Impact factor: 5.226

Review 8.  Genital herpes simplex virus type 1 infection: new fields for an old acquaintance?

Authors:  Lars Lippelt; Rüdiger W Braun; Joachim E Kühn
Journal:  Intervirology       Date:  2002       Impact factor: 1.763

9.  Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates.

Authors:  Gun-Britt Löwhagen; Petra Tunbäck; Tomas Bergström
Journal:  Acta Derm Venereol       Date:  2002       Impact factor: 4.437

10.  Natural history of genital herpes simplex virus type 1 infection.

Authors:  Rebecca Engelberg; David Carrell; Elizabeth Krantz; Lawrence Corey; Anna Wald
Journal:  Sex Transm Dis       Date:  2003-02       Impact factor: 2.830

View more
  21 in total

1.  Herpes diagnostic tests and their use.

Authors:  Nicholas J Van Wagoner; Edward W Hook
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

Review 2.  Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.

Authors:  Rebecca G Edwards; Richard Longnecker
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

Review 3.  HSV-2 serology can be predictive of HIV epidemic potential and hidden sexual risk behavior in the Middle East and North Africa.

Authors:  Laith J Abu-Raddad; Joshua T Schiffer; Rhoda Ashley; Ghina Mumtaz; Ramzi A Alsallaq; Francisca Ayodeji Akala; Iris Semini; Gabriele Riedner; David Wilson
Journal:  Epidemics       Date:  2010-09-15       Impact factor: 4.396

4.  Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003.

Authors:  L J Haddow; B Dave; A Mindel; K A McPhie; C Chung; C Marks; D E Dwyer
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

5.  Using centralized laboratory data to monitor trends in herpes simplex virus type 1 and 2 infection in British Columbia and the changing etiology of genital herpes.

Authors:  Mark Gilbert; Xuan Li; Martin Petric; Mel Krajden; Judith L Isaac-Renton; Gina Ogilvie; Michael L Rekart
Journal:  Can J Public Health       Date:  2011 May-Jun

6.  Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey.

Authors:  A L Cunningham; R Taylor; J Taylor; C Marks; J Shaw; A Mindel
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

7.  Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords.

Authors:  Alison J Johnson; Chin-Fun Chu; Gregg N Milligan
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

Review 8.  Clinical and therapeutic issues for herpes simplex virus-2 and HIV co-infection.

Authors:  Jairam R Lingappa; Connie Celum
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood.

Authors:  Elisabeth I Laderman; Emma Whitworth; Erickson Dumaual; Mark Jones; Andrew Hudak; Wayne Hogrefe; Jim Carney; Jan Groen
Journal:  Clin Vaccine Immunol       Date:  2007-11-14

10.  High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection.

Authors:  Zheming Lu; Richard Brans; Natali V Akhrameyeva; Nao Murakami; Ximing Xu; Feng Yao
Journal:  J Invest Dermatol       Date:  2008-11-13       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.